RESUMO
The introduction of a stand-alone Bone Bank in our Regional Orthopaedic Hospital has improved the availability of femoral head allograft. Benninger et al. (Bone Joint J 96-B:1307-1311, 2014), demonstrated their institutions bank to be cost effective despite a 30 % discard rate for harvested allograft. We sought to audit our own discard rates and subsequent cost-effectiveness of our bone bank. Donor recruitment. Before approaching a potential donor, our establishment's nurse specialists review their clinical notes and biochemical laboratory results, available on a regional Electronic Care Records. They view femoral head architecture on radiographs against set criteria, Patient Archive and Communication system (SECTRA, Sweden). In total 1383 femoral heads were harvested, 247 were discarded giving an overall rate of 17.9 %. The most common reasons for discard of harvested graft was a positive microbiology/bacteriology result, n = 96 (38.9 %). After a rise in discard rates in 2007, we have steadily reduced our discard rates since 2006/2007 (28.2 %), 2008/2009 (17 %), 2010/2011 (14.8 %), and finally to 10.3 % in 2012/2013. In the current financial year, our cost to harvest, test, store and release a femoral head is £ 610. With a structured donor recruitment process and unique pre-operative radiographic analysis we have successfully reduced our discard rates bi-annually making our bone bank increasingly cost-effective.
Assuntos
Bancos de Ossos/normas , Bactérias/isolamento & purificação , Custos e Análise de Custo , Cabeça do Fêmur/diagnóstico por imagem , Humanos , Doadores de Tecidos , Coleta de Tecidos e Órgãos/economiaRESUMO
Bone allografts have been used widely to fill up essential void in orthopaedic surgeries. The benefit of using allografts to replace and reconstruct musculoskeletal injuries, fractures or disease has obtained overwhelming acceptance from orthopaedic surgeons worldwide. However, bacterial infection and disease transmission through bone allograft transplantation have always been a significant issue. Sterilization by radiation is an effective method to eliminate unwanted microorganisms thus assist in preventing life threatening allograft associated infections. Femoral heads procured from living donors and long bones (femur and tibia) procured from cadaveric donors were sterilized at 25 kGy in compliance with international standard ISO 11137. According to quality requirements, all records of bone banking were evaluated annually. This retrospective study was carried out on annual evaluation of radiation records from 1998 until 2012. The minimum doses absorbed by the bones were ranging from 25.3 to 38.2 kGy while the absorbed maximum doses were from 25.4 to 42.3 kGy. All the bones supplied by our UMMC Bone Bank were sterile at the required minimum dose of 25 kGy. Our analysis on dose variation showed that the dose uniformity ratios in 37 irradiated boxes of 31 radiation batches were in the range of 1.003-1.251, which indicated the doses were well distributed.
Assuntos
Bancos de Ossos/normas , Transplante Ósseo/normas , Osso e Ossos/microbiologia , Osso e Ossos/efeitos da radiação , Criopreservação/normas , Esterilização/normas , Aloenxertos/normas , Bactérias/efeitos da radiação , Bancos de Ossos/estatística & dados numéricos , Transplante Ósseo/estatística & dados numéricos , Criopreservação/métodos , Criopreservação/estatística & dados numéricos , Relação Dose-Resposta à Radiação , Raios gama , Fidelidade a Diretrizes , Humanos , Malásia , Auditoria Médica , Guias de Prática Clínica como Assunto , Doses de Radiação , Estudos Retrospectivos , Esterilização/estatística & dados numéricosRESUMO
AB Archival samples represent a significant potential for genetic studies, particularly in severe diseases with risk of lethal outcome, such as in cancer. In this pilot study, we aimed to evaluate the usability of archival bone marrow smears and biopsies for DNA extraction and purification, whole genome amplification (WGA), multiple marker analysis including 10 short tandem repeats, and finally a comprehensive genotyping of 33,683 single nucleotide polymorphisms (SNPs) with multiplexed targeted next-generation sequencing. A total of 73 samples from 21 bone marrow smears and 13 bone marrow biopsies from 18 Danish and Norwegian childhood acute lymphoblastic leukemia patients were included and compared with corresponding blood samples. Samples were grouped according to the age of sample and whether WGA was performed or not. We found that measurements of DNA concentration after DNA extraction was dependent on detection method and that spectrophotometry overestimated DNA amount compared with fluorometry. In the short tandem repeat analysis, detection rate dropped slightly with longer fragments. After WGA, this drop was more pronounced. Samples stored for 0 to 3 years showed better results compared with samples stored for 4 to 10 years. Acceptable call rates for SNPs were detected for 7 of 42 archival samples. In conclusion, archival bone marrow samples are suitable for DNA extraction and multiple marker analysis, but WGA was less successful, especially when longer fragments were analyzed. Multiple SNP analysis seems feasible, but the method has to be further optimized.
Assuntos
Biomarcadores Tumorais/análise , Medula Óssea/fisiologia , DNA/análise , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Adolescente , Biópsia , Bancos de Ossos/normas , Criança , Pré-Escolar , DNA/isolamento & purificação , Dinamarca , Feminino , Fluorometria , Genoma/genética , Genótipo , Humanos , Masculino , Repetições de Microssatélites/genética , Noruega , Projetos Piloto , Polimorfismo de Nucleotídeo Único , Leucemia-Linfoma Linfoblástico de Células Precursoras/genética , Manejo de Espécimes , EspectrofotometriaRESUMO
We analyzed the incidence and predisposing factors for overall discard rate after retrieval of 295 femoral head allografts. The aim of the present study was to evaluate the quality system of institutional bone banking and to ensure that we can provide high standard allografts with low infection rate. Audit of bone banking was conducted on 295 donors and 180 recipients. Of the 295 donated femoral heads 77 were discarded, giving an overall discard rate of 26.1 %. At retrieval, 37 allografts were positive, giving an overall contamination rate of 12.54 %. The organism most commonly identified was Staphylococcus species. Seven (2.37 %) of the 295 allografts failed the blood screening tests. Twelve allografts (4.06 %) were discarded because of suspected damage of the packaging or disuse during surgery. Due to donor death or inability to perform serology retests, 21 (7.11 %) allografts were discarded. In the postoperative survey an infection rate of 2.22 % was found. After 7 years of bone banking, our results show that overall discard rate and allograft related infection rate are in accordance with the international standards. The leading cause of allograft discarding was bacterial contamination influenced by the surgical team. We suggest stringent aseptic allograft handling during harvesting and thawing within highly concentrated antibiotic solution to reduce a possibility of its contamination.
Assuntos
Infecções Bacterianas/epidemiologia , Bancos de Ossos/normas , Transplante Ósseo/normas , Auditoria Clínica/normas , Cabeça do Fêmur/transplante , Adulto , Idoso , Idoso de 80 Anos ou mais , Aloenxertos , Antibacterianos/uso terapêutico , Infecções Bacterianas/prevenção & controle , Criopreservação/normas , Feminino , Cabeça do Fêmur/microbiologia , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Estudos Retrospectivos , Sérvia/epidemiologiaRESUMO
The new tissue laws of 2007 created a completely new situation for German musculoskeletal tissue banks. The objective of the new regulations in the recent German tissue act is to improve safety by reducing the risk of transmission of viral and nonviral diseases. Since 2007 tissue banks have to declare their intention to continue providing allografts to the local authorities until August 2011 based on the guidelines of the Federal Medical Association (Bundesärztekammer 2001) and according to § 144 of the Pharmaceutical Products Act (Arzneimittelgesetz). The Orthopedic University Clinic in Ulm applied for registration according to § 20 b and c of the Pharmaceutical Products Act in 2010. After submitting all the required documents, government officials controlled the equipment, distribution of responsible personnel, location of operating theatres and the laboratory and quality assurance documentation. After alluding to the lack of validation for the use of a hemoculture medium for testing ringer lactate solutions, permission according to § 20 b and c was granted with the obligation to transfer all serological and microbiological testing of tissue donors to another laboratory with its own approval under § 20 c of the Pharmaceutical Products Act.
Assuntos
Centros Médicos Acadêmicos/legislação & jurisprudência , Centros Médicos Acadêmicos/normas , Bancos de Ossos/legislação & jurisprudência , Bancos de Ossos/normas , Ortopedia/legislação & jurisprudência , Ortopedia/normas , Guias de Prática Clínica como Assunto , Alemanha , Fidelidade a Diretrizes/legislação & jurisprudênciaRESUMO
INTRODUCTION: Since 1981, the Singapore General Hospital (SGH) bone bank has proven to be a safe, reliable, and economical source of bone allografts. Femoral heads are used exclusively and are procured from patients undergoing hip arthroplasty. Screening for HIV, hepatitis B, and hepatitis C is carried out prior to surgery. Patients with ongoing infection and past history of malignancy are excluded. The bone graft procured is washed and autoclaved to 134°C for 3 minutes. It is then stored in saline solution containing penicillin and streptomycin at -80°C. Based on our experience, such a system can be readily duplicated in developing nations with minimal cost and equipment. This article presents our experience in the procurement and storage of femoral head allografts with clinical results to support the safety profile. METHODS: Ten femoral heads were harvested from patients who underwent hip arthroplasty. The femoral heads were autoclaved and stored at -80°C in an antibiotic solution. Bone chips were sent for culture immediately after autoclaving and at 3 and 6 months. RESULTS: All specimens passed the initial sterility testing and remained sterile up to 6 months. A retrospective study of 9 patients who had 13 allografts implanted between 2008 and 2010 showed that none of the recipients acquired an infection or transmissible disease due to the allografts. CONCLUSION: This study showed that our protocol allows for procurement of femoral head allografts with minimal contamination and that they can maintain sterility for up to 6 months. This finding is further supported by our clinical results. Hence, this protocol will be useful for bone banks in developing nations where sterility conditions are suboptimal and cost is an issue.
Assuntos
Bancos de Ossos/organização & administração , Bancos de Ossos/normas , Cabeça do Fêmur/transplante , Preservação de Órgãos/métodos , Cabeça do Fêmur/microbiologia , Hospitais Gerais , Humanos , Preservação de Órgãos/economia , Soluções para Preservação de Órgãos , Projetos Piloto , Singapura , Coleta de Tecidos e ÓrgãosRESUMO
BACKGROUND: Availability of allograft tympano-ossicular systems (ATOS) provides unique reconstructive capabilities, allowing more radical removal of middle ear pathology. To provide ATOS, the University of Antwerp Temporal Bone Bank (UATB) was established in 1988. ATOS use was stopped in many countries because of safety issues concerning human tissue transplantation. Our objective was to maintain an ATOS tissue bank complying with European Union (EU) directives on human tissues and cells. METHODS: The guidelines of the Belgian Superior Health Council, including EU directive requirements, were rigorously applied to UATB infrastructure, workflow protocols and activity. Workflow protocols were updated and an internal audit was performed to check and improve consistency with established quality systems and changing legislations. The Belgian Federal Agency of Medicines and Health Products performed an inspection to examine compliance with national legislatives and EU directives on human tissues and cells. A sample of important procedures was meticulously examined in its workflow setting next to assessment of the infrastructure and personnel. RESULTS: Results are reported on infrastructure, personnel, administrative workflow, procurement, preparation, processing, distribution, internal audit and inspection by the competent authority. Donors procured: 2006, 93 (45.1%); 2007, 64 (20.6%); 2008, 56 (13.1%); 2009, 79 (6.9%). The UATB was approved by the Minister of Health without critical or important shortcomings. The Ministry accords registration each time for 2 years. CONCLUSIONS: An ATOS tissue bank complying with EU regulations on human allografts is feasible and critical to assure that the patient receives tissue, which is safe, individually checked and prepared in a suitable environment.
Assuntos
Bancos de Ossos/legislação & jurisprudência , União Europeia , Fidelidade a Diretrizes/legislação & jurisprudência , Osso Temporal , Transplante/legislação & jurisprudência , Bancos de Ossos/normas , Células , Auditoria Clínica/normas , Documentação , Seleção do Doador , Fidelidade a Diretrizes/normas , Humanos , Preservação de Órgãos/normas , Transplante/normas , Universidades , Recursos HumanosRESUMO
The use of bone grafts is a common practice in musculoskeletal surgery to provide mechanical stability where there is a defect and it allows skeletal reconstruction. Classically auto and allografts have been used. The latter are the choice in large, complex defects. Allografts can be transplanted despite cell death, have osteoconduction and osteoinduction capacity, low antigenicity and biomechanical properties similar to the original bone. They can be obtained from living and death donors. They are stored by cryopreservation and lyophilization in entities called bone banks. This is a review about bone allografts and the organization and function of the bone banks.
Assuntos
Bancos de Ossos/organização & administração , Transplante Ósseo , Osso e Ossos , Preservação de Tecido/métodos , Bancos de Ossos/normas , Transplante Ósseo/efeitos adversos , Transplante Ósseo/imunologia , Humanos , Objetivos Organizacionais , Obtenção de Tecidos e Órgãos , Transplante HomólogoRESUMO
The use of bone grafts is a common practice in musculoskeletal surgery to provide mechanical stability where there is a defect and it allows skeletal reconstruction. Classically auto and allografts have been used. The latter are the choice in large, complex defects. Allografts can be transplanted despite cell death, have osteoconduction and osteoinduction capacity, low antigenicity and biomechanica lproperties similar to the original bone. They can be obtained from living and death donors. They are stored by cryopreservation and lyophilization in entities called bone banks. This is a review about bone allografts and the organization and function of the bone banks.
Assuntos
Humanos , Bancos de Ossos/organização & administração , Transplante Ósseo , Osso e Ossos , Preservação de Tecido/métodos , Bancos de Ossos/normas , Transplante Ósseo/efeitos adversos , Transplante Ósseo/imunologia , Objetivos Organizacionais , Obtenção de Tecidos e Órgãos , Transplante HomólogoRESUMO
Allograft bone is commonly used in reconstructive orthopaedic surgery and needs to be assessed for bioburden before transplant. The Microbiology Department of the South Eastern Area Laboratory Services (SEALS), located at the St. George Hospital, Sydney, has provided this service to the New South Wales (NSW) Bone Bank. This study reviewed the organisms isolated from femoral head allografts of living donors from the NSW Bone Bank over a 7-year period. It was found that growth was reported from 4.9% of samples with the predominant organism being coagulase-negative staphylococci. This review will focus on the micro-organisms isolated, the interaction of the laboratory with the bone bank, the relevance of the bioburden assessment in the overall quality process and patient safety.
Assuntos
Bancos de Ossos , Transplante Ósseo , Cabeça do Fêmur/microbiologia , Cabeça do Fêmur/transplante , Técnicas Microbiológicas/métodos , Bactérias/isolamento & purificação , Bancos de Ossos/normas , Transplante Ósseo/efeitos adversos , Fungos/isolamento & purificação , Humanos , Técnicas de Cultura de Tecidos , Transplante HomólogoRESUMO
Tumor excision is the primary treatment of aggressive or recurrent benign bone tumors and malignant bone sarcomas. This requires a surgical resection with the potential for large residual osseous defects that could be reconstructed using fresh frozen allografts. Virtual bone banks enable the creation of databases allowing a 3D pre-surgery evaluation of such allgorafts, based on segmentation of DICOM-CT images. This study demonstrates the usefulness of patient specific 3D models for an accurate host-donor allograft match. We describe one way to select the best match according to size and shape. The results suggest that a robust and reliable technique has been established. Since it is difficult to plan an allograft on a distal femur deformed by the tumor, we propose to plan the surgery on the contralateral side. Our results support this limb symmetry hypothesis. The use of this measurement protocol enables accurate selection of allografts from a contralateral healthy femur 3D CT model achieving the best match possible considering the geometry of available allograft candidate femur specimens.
Assuntos
Bancos de Ossos , Fêmur/diagnóstico por imagem , Fêmur/transplante , Imageamento Tridimensional/métodos , Tomografia Computadorizada por Raios X , Adolescente , Bancos de Ossos/normas , Transplante Ósseo/métodos , Feminino , Humanos , Masculino , Tamanho do Órgão , Transplante Homólogo , Adulto JovemRESUMO
In Malaysia, tissue banking activities began in Universiti Sains Malaysia (USM) Tissue Bank in early 1990s. Since then a few other bone banks have been set up in other government hospitals and institutions. However, these banks are not governed by the national authority. In addition there is no requirement set by the national regulatory authority on coding and traceability for donated human tissues for transplantation. Hence, USM Tissue Bank has taken the initiatives to adopt a system that enables the traceability of tissues between the donor, the processed tissue and the recipient based on other international standards for tissue banks. The traceability trail has been effective and the bank is certified compliance to the international standard ISO 9001:2008.
Assuntos
Processamento Eletrônico de Dados/normas , Obtenção de Tecidos e Órgãos/normas , Transplantes/normas , Bancos de Ossos/normas , Humanos , Malásia , Bancos de Tecidos , Obtenção de Tecidos e Órgãos/métodosRESUMO
BACKGROUND: A relatively high incidence of pathological conditions in retrieved femoral heads, including a group of patients having low grade B-cell lymphoma, has been described before. At short term follow up none of these patients with low-grade B-cell lymphoma showed evidence of systemic disease. However, the long term follow up of these patients is not known. METHODS: From November 1994 up to and including December 2005 we screened all femoral heads removed at the time of primary total hip replacement histopathologically and included them in the bone banking protocol according to the guidelines of the American Associations of Tissue Banks (AATB) and the European Association of Musculo-Skeletal Transplantation (EAMST). We determined the percentage of B-cell lymphoma in all femoral heads and in the group that fulfilled all criteria of the bone banking protocol and report on the long-term follow-up. RESULTS: Of 852 femoral heads fourteen (1.6%) were highly suspicious for low-grade B-cell lymphoma. Of these 852 femoral heads, 504 were eligible for bone transplantation according to the guidelines of the AATB and the EAMST. Six femoral heads of this group of 504 were highly suspicious for low-grade B-cell lymphoma (1.2%). At long term follow up two (0.2%) of all patients developed systemic malignant disease and one of them needed medical treatment for her condition. CONCLUSION: In routine histopathological screening we found variable numbers of low-grade B-cell lymphoma throughout the years, even in a group of femoral heads that were eligible for bone transplantation. Allogenic transmission of malignancy has not yet been reported on, but surviving viruses are proven to be transmissible. Therefore, we recommend the routine histopathological evaluation of all femoral heads removed at primary total hip arthroplasty as a tool for quality control, whether the femoral head is used for bone banking or not.
Assuntos
Bancos de Ossos/normas , Transplante Ósseo/efeitos adversos , Cabeça do Fêmur/transplante , Linfoma de Células B/epidemiologia , Transplante Homólogo/efeitos adversos , Adulto , Idoso , Idoso de 80 Anos ou mais , Artroplastia de Quadril/normas , Progressão da Doença , Transmissão de Doença Infecciosa/prevenção & controle , Feminino , Cabeça do Fêmur/patologia , Seguimentos , Humanos , Incidência , Linfoma de Células B/patologia , Masculino , Programas de Rastreamento/métodos , Pessoa de Meia-Idade , Fatores de Tempo , Coleta de Tecidos e Órgãos/normas , Adulto JovemRESUMO
Allograft bone has been used safely and extensively in dental and implant surgery for more than 35 years, and increased federal regulation only serves to enhance an exceptional safety record. However, proper selection of tissue from accredited banks by a knowledgeable clinician, and compliance with tracking and recordkeeping recommendations, will provide the ultimate benefit to the patients who trust our clinical judgment for their wellbeing.
Assuntos
Processo Alveolar/cirurgia , Bancos de Ossos/normas , Transplante Ósseo/métodos , Animais , Bovinos , Humanos , Transplante HomólogoRESUMO
Allografts of bone from the femoral head are often used in orthopaedic procedures. Although the donated heads are thoroughly tested microscopically before release by the bone bank, some surgeons take additional cultures in the operating theatre before implantation. There is no consensus about the need to take these cultures. We retrospectively assessed the clinical significance of the implantation of positive-cultured bone allografts. The contamination rate at retrieval of the allografts was 6.4% in our bone bank. Intra-operative cultures were taken from 426 femoral head allografts before implantation; 48 (11.3%) had a positive culture. The most frequently encountered micro-organism was coagulase-negative staphylococcus. Deep infection occurred in two of the 48 patients (4.2%). In only one was it likely that the same micro-organism caused the contamination and the subsequent infection. In our study, the rate of infection in patients receiving positive-cultured allografts at implantation was not higher than the overall rate of infection in allograft surgery suggesting that the positive cultures at implantation probably represent contamination and that the taking of additional cultures is not useful.
Assuntos
Bactérias/isolamento & purificação , Infecções Bacterianas/transmissão , Cabeça do Fêmur/microbiologia , Infecções Bacterianas/prevenção & controle , Bancos de Ossos/normas , Transplante Ósseo , Cabeça do Fêmur/transplante , Humanos , Estudos Retrospectivos , Transplante HomólogoRESUMO
The transplantation of allogenic tissue (bone, cartilage, tendon, skin, amnion and special preparations such as demineralised bone matrix and acellular dermis) is an important component of the treatment of bone and soft tissue defects, particularly in traumatology and orthopaedic, reconstructive and plastic surgery. In Germany, the requirement for such tissue transplants is met by supply from local tissue banks (in particular bone banks) and a small number of regional and national tissue banks. These banks operate on the basis of the "Guidelines for Bone Banks" laid down by the German Chamber of Physicians, and of the German Drug Law (AMG). The 2004/23/EG guidelines issued by the European Parliament and ratified on 31/3/2004 define the quality and safety standards for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. These guidelines will have a major impact on all aspects of tissue banking and transplantation. In particular, the new guidelines will remove the possibility for local tissue banks to operate outside of national drug laws ( section sign 4 a [4]). The currently in draft law on "Quality and Safety of Human Tissues and Cells" ("Tissue Law") of the Federal Health Ministry seems to be heading in this direction, but it also includes possibilities for the continuation of local banks. An additional European guideline draft "Proposal for the regulation of advanced therapeutic medical products" is currently under discussion. This paper assesses the impact of these new pieces of legislation on the quality, safety and availability of human cell and tissue transplants in terms of the current situation and future prospects in Germany.
Assuntos
Bancos de Ossos/legislação & jurisprudência , Transplante de Células/legislação & jurisprudência , Legislação de Medicamentos , Bancos de Tecidos/legislação & jurisprudência , Transplante de Tecidos/legislação & jurisprudência , Bancos de Ossos/normas , Transplante de Células/normas , Europa (Continente) , Alemanha , Humanos , Queratinócitos/transplante , Guias de Prática Clínica como Assunto , Qualidade da Assistência à Saúde , Segurança , Bancos de Tecidos/normas , Transplante de Tecidos/normasAssuntos
Transplante de Células/legislação & jurisprudência , Legislação de Medicamentos , Bancos de Tecidos/legislação & jurisprudência , Transplante de Tecidos/legislação & jurisprudência , Bancos de Ossos/legislação & jurisprudência , Bancos de Ossos/normas , Cadáver , Transplante de Células/normas , Alemanha , Humanos , Preparações Farmacêuticas , Qualidade da Assistência à Saúde , Transplante de Pele/legislação & jurisprudência , Transplante de Pele/normas , Bancos de Tecidos/normas , Doadores de Tecidos , Transplante de Tecidos/normasRESUMO
BACKGROUND: The EU guidelines 2004/23/EG and 2006/17/EG and their national implementation redefine the framework for allogenic bone banking and transplantation. Against this background an established internal hospital bone bank was analysed concerning threshold of allogenic bone and cost effectiveness in comparison to alternative methods. METHOD: Over a 30-month period we registered all arrivals and outgoings of our bone bank and their destination. We further noted all declined donations. We analysed all costs incurred and calculated costs for alternative methods. RESULTS: By means of our bone bank we are currently able to meet our own demand for bone substitutes. The maintenance costs are below the prices of alternative methods. Some donations (8%) have to be discarded due to procedural errors. CONCLUSION: Maintaining an internal hospital bone bank utilizing fresh-frozen allogenic bone is an efficient and cost-effective method of supplying bone substitutes even under the new EU guidelines if the existing process covers most conditions of the producer authorisation according to section sign 13 AMG. By harmonizing the organizational process it is possible to further improve its effectiveness.
Assuntos
Bancos de Ossos/economia , Bancos de Ossos/estatística & dados numéricos , Eficiência Organizacional/economia , Eficiência Organizacional/estatística & dados numéricos , Custos de Cuidados de Saúde/estatística & dados numéricos , Departamentos Hospitalares/economia , Departamentos Hospitalares/estatística & dados numéricos , Bancos de Ossos/normas , Análise Custo-Benefício , Atenção à Saúde/economia , Atenção à Saúde/normas , Atenção à Saúde/estatística & dados numéricos , Eficiência Organizacional/normas , União Europeia , Alemanha , Custos de Cuidados de Saúde/normas , Departamentos Hospitalares/normas , Garantia da Qualidade dos Cuidados de Saúde/economia , Garantia da Qualidade dos Cuidados de Saúde/normas , Garantia da Qualidade dos Cuidados de Saúde/estatística & dados numéricosAssuntos
Bancos de Ossos/normas , Bancos de Tecidos/normas , Fundações/tendências , Colômbia , Esterilização/normas , Laboratórios , Liofilização/métodos , Técnica de Desmineralização Óssea/métodos , Transplante Ósseo/instrumentação , Transplante Ósseo/normas , Transplante de Tecidos/instrumentação , Transplante de Tecidos/normasRESUMO
For several decades, a dose of 25 kGy of gamma irradiation has been recommended for terminal sterilization of medical products, including bone allografts. Practically, the application of a given gamma dose varies from tissue bank to tissue bank. While many banks use 25 kGy, some have adopted a higher dose, while some choose lower doses, and others do not use irradiation for terminal sterilization. A revolution in quality control in the tissue banking industry has occurred in line with development of quality assurance standards. These have resulted in significant reductions in the risk of contamination by microorganisms of final graft products. In light of these developments, there is sufficient rationale to re-establish a new standard dose, sufficient enough to sterilize allograft bone, while minimizing the adverse effects of gamma radiation on tissue properties. Using valid modifications, several authors have applied ISO standards to establish a radiation dose for bone allografts that is specific to systems employed in bone banking. These standards, and their verification, suggest that the actual dose could be significantly reduced from 25 kGy, while maintaining a valid sterility assurance level (SAL) of 10(-6). The current paper reviews the methods that have been used to develop radiation doses for terminal sterilization of medical products, and the current trend for selection of a specific dose for tissue banks.